Browse > Article

Determining Anti-impotence drug-like compounds in Food  

Choi, Dongmi (Korea Food & Drug Administration)
Im, Mooheg (Korea Food & Drug Administration)
Lee, Kyungjin (Korea Food & Drug Administration)
Kwon, Kwangil (Korea Food & Drug Administration)
Jeong, Jiyoon (Korea Food & Drug Administration)
Park, Gunsang (Korea Food & Drug Administration)
Hong, Mooki (Korea Food & Drug Administration)
Lee, Chulwon (Korea Food & Drug Administration)
Publication Information
Analytical Science and Technology / v.17, no.6, 2004 , pp. 520-526 More about this Journal
Abstract
To determine 6 anti-impotence drug-like compounds such as sildenafil, vardenafil, tadalafil, homosildenafil, hydroxyhomosildenafil and hongdenafil in food, simultaneously, high performance liquid chromatography was applied. In the case of solid sample, it was extracted in organic solvents after homogenizing with mortar and pestle. Whereas liquid sample was just diluted in water and then extracted in organic solvents. Maximum lengths of UV for targets have been identified on photodiode array spectra. As results, vardenafil, hongdenafil, hydroxyhomosildenafil, sildenafil, homosildenafil, and tadalafil were eluted in order using $C_{18}$ column in acetonitrile containing phosphoric acid as the mobile phase. The maximum wavelength (${\lambda}_{max}$) was 216 nm for vardenafil, 233 and 282 nm for hongdenafil, 222 and 293 nm for hydroxyhomosildenafil, sildenafil and homosildenafil, and 284 nm for tadalafil. The overall recoveries were ranged from 95% to 109% and the limit of detection was about 0.04 mg/kg at signal/noise>3. Levels of targets in the selected food samples were 1.7 (hongdenafil) ~ 63 (tadalafil) mg/one dose.
Keywords
hongdenafil; hydroxyhomosildenafil; homosildenafil; food; HPLC;
Citations & Related Records
연도 인용수 순위
  • Reference
1 오.남용우려의약품지정등에관한규정, 식품의약품안전청 고시 제2002-7호, 2002.2.18. (http://www.kfda.go.kr/cgi-bin/t4.cgi/drug/drug1.taf?f=9).
2 C. Shin, M. Hong, D. Kim, Y. Lim, Magn. Res. Chem., 42 (2004) in press.
3 R. Rosen, J. Kostis, Am. J. Cardiol,. 92, 9M-18M(2003).
4 Health Canada Warnings (http://www.hc-sc.gc.ca/english/protection/warnings/2003/2003_35.html).
5 신명희, 홍무기, 김우성, 이영자, 식품의약품안전청 연보, 39, 121-124(2002).
6 명승운, 박서희, 조현우, 분석과학, 16, 488-498(2003).
7 식품의약품안전청 보도/해명자료 (http://www.kfda.go.kr).
8 M. Sheu, A. Wu, G. Yeh, A. Hsia, H. Ho, Y. Jeoung, J. Chromatogr. B, 791, 255-262(2003).
9 US FDA Talk Paper (http://fda.gov/bbs/topics/ANSWERS/2003/ANS01235.html).
10 식품공전, 식품의약품안전청 (2002).
11 E. Boyce, E. Umland, Clinical Therapeutics, 23, 2-23(2001).
12 장재희, 박건상, 박혜경, 구용의, 최윤주, 황인경, 김대병, J. Fd. Hyg. Safety, 18, 177-182(2003).
13 日本 厚生勞働省 報道發表資料 (http://mhlw.go.jp/houdou/2004/02/h0213-3.html).
14 식품위생법, 보건복지부 (2003.8).
15 J. Kim, H. Ji, S. Kim, H. Lee, S. Lee, D. Kim, M. Yoo, W. Kim, H. Lee, J. Pharm. Biomed. Anal., 32, 317-322(2003).
16 G. Brock, Eur. Urol. Suppl., 1, 12-18(2002).
17 M. Shin, M. Hong, W. Kim, Y. Lee, Y. Jeoung, Food Addit. Contam., 20, 793-796(2003).
18 식품중 발기부전치료제및유사물질(행정간행물 등록번호; 11-1470000-000528-01), 식품의약품안전청 식품안전평가부, 2004.